Glofitamab

• Target :

  Integrin|||Immunology/Inflammation related|||Others

• Related Pathways :

  Others|||Cytoskeletal Signaling|||Immunology/Inflammation

• Purity :

  0.984

• Bioactivity :

  Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2229047-91-8